TrialJournal of pharmacokinetics and pharmacodynamics2019

Cabozantinib exposure-response analyses of efficacy and safety in patients with advanced hepatocellular carcinoma.

Linh Nguyen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.